Spinal cord atrophy in anterior‐posterior direction reflects impairment in multiple sclerosis

Objective To investigate how atrophy is distributed over the cross section of the upper cervical spinal cord and how this relates to functional impairment in multiple sclerosis (MS). Methods We analysed the structural brain MRI scans of 54 patients with relapsing‐remitting MS (n=22), primary progres...

Full description

Saved in:
Bibliographic Details
Published inActa neurologica Scandinavica Vol. 136; no. 4; pp. 330 - 337
Main Authors Lundell, H., Svolgaard, O., Dogonowski, A.‐M., Romme Christensen, J., Selleberg, F., Soelberg Sørensen, P., Blinkenberg, M., Siebner, H. R., Garde, E.
Format Journal Article
LanguageEnglish
Published Denmark Hindawi Limited 01.10.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective To investigate how atrophy is distributed over the cross section of the upper cervical spinal cord and how this relates to functional impairment in multiple sclerosis (MS). Methods We analysed the structural brain MRI scans of 54 patients with relapsing‐remitting MS (n=22), primary progressive MS (n=9), secondary progressive MS (n=23) and 23 age‐ and sex‐matched healthy controls. We measured the cross‐sectional area (CSA), left‐right width (LRW) and anterior‐posterior width (APW) of the spinal cord at the segmental level C2. We tested for a nonparametric linear relationship between these atrophy measures and clinical impairments as reflected by the Expanded Disability Status Scale (EDSS) and Multiple Sclerosis Impairment Scale (MSIS). Results In patients with MS, CSA and APW but not LRW were reduced compared to healthy controls (P<.02) and showed significant correlations with EDSS, MSIS and specific MSIS subscores. Conclusion In patients with MS, atrophy of the upper cervical cord is most evident in the antero‐posterior direction. As APW of the cervical cord can be readily derived from standard structural MRI of the brain, APW constitutes a clinically useful neuroimaging marker of disease‐related neurodegeneration in MS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0001-6314
1600-0404
DOI:10.1111/ane.12729